IMAC Holdings to Participate at the Benzinga Global Small Cap Conference and Present to Investors on December 8, 2021
IMAC Holdings announces its participation in the Benzinga Global Small Cap Conference, scheduled for December 8-9, 2021. CEO Jeffrey Ervin will present on December 8 at 10:50 AM ET. The company focuses on innovative, non-surgical orthopedic treatments and operates health and wellness centers specializing in sports medicine and rehabilitation.
Investors can request one-on-one meetings with Mr. Ervin following the conference. More details about the conference registration can be found here.
- None.
- None.
BRENTWOOD, Tenn., Dec. 06, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative and rehabilitative orthopedic treatments without the use of surgery or opioids, today announces that management will participate at the Benzinga Global Small Cap Conference, which is being held virtually from December 8 – 9, 2021.
Chief Executive Officer Jeffrey Ervin will deliver his corporate presentation on Wednesday, December 8, 2021, at 10:50am ET.
Investors can also request a one-on-one meeting with Mr. Ervin to be arranged following the conclusion of the conference.
Investors can register for the conference here:
https://www.benzinga.com/events/small-cap/december-2021-global/
About IMAC Holdings, Inc.
IMAC Holdings owns and manages health and wellness centers that deliver sports medicine, orthopedic, and life science therapies for movement restricting diseases. IMAC is comprised of three business segments: outpatient medical centers, The Back Space, and a clinical research division. With treatments to address the aging population, IMAC Holdings owns or manages more than 15 outpatient medical clinics and has partnered with several active and former professional athletes, including Ozzie Smith, David Price, Mike Ditka, and Tony Delk to promote a minimally invasive approach to sports medicine. IMAC’s The Back Space retail spine health and wellness treatment centers deliver chiropractic care within Walmart locations. IMAC’s research division is currently conducting a Phase I clinical trial evaluating a mesenchymal stem cell therapy candidate for bradykinesia due to Parkinson’s disease. For more information visit www.imacholdings.com.
# # #
Safe Harbor Statement
This press release contains forward-looking statements. These forward-looking statements, and terms such as “anticipate,” “expect,” “believe,” “may,” “will,” “should” or other comparable terms, are based largely on IMAC's expectations and are subject to a number of risks and uncertainties, certain of which are beyond IMAC's control. Actual results could differ materially from these forward-looking statements as a result of, among other factors, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the skills and experience necessary to meet customers’ requirements, and its ability to protect its intellectual property. IMAC encourages you to review other factors that may affect its future results in its registration statement and in its other filings with the Securities and Exchange Commission. In light of these risks and uncertainties, there can be no assurance that the forward-looking information contained in this press release will in fact occur.
IMAC Press Contact:
Laura Fristoe
Investor Relations:
Bret Shapiro
(516) 222-2560
FAQ
What is the date of IMAC's presentation at the Benzinga Global Small Cap Conference?
How can investors meet with IMAC’s CEO following the Benzinga conference?
What is IMAC Holdings' focus in medical treatments?
Where can I register for the Benzinga Global Small Cap Conference?
